MKC vs STRO
McCormick & Company Incorporated (MKC) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
McCormick & Company Incorporated (MKC) is a packaged foods company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
MKC does not have a complete income-statement cache yet.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
MKC currently screens at market cap $13.56B and trailing P/E 8.4. STRO currently screens at market cap $470.8M.
Not investment advice. Open the MKC and STRO stock pages for the full models.
Not investment advice.